Successful use of recombinant human thyrotropin in the therapy of pediatric well-differentiated thyroid cancer

Journal of Endocrinological Investigation

Volumn 28, Issue 5, 2005, Pages 270-273

  Ralli, M ^a   Cohan, P ^b   Lee, K ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

131I therapy; Pediatrics; Recombinant human thyrotropin (rhTSH); Well differentiated thyroid cancer

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; RECOMBINANT PROTEIN; THYROTROPIN;

ANAMNESIS; ARTICLE; CYTOLOGY; FREE THYROXINE INDEX; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; METASTASIS; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; THYROID CANCER; THYROIDECTOMY; TRACHEOSTOMY; X RAY; ADOLESCENT; BLOOD; CASE REPORT; MALE; MULTIMODALITY CANCER THERAPY; PAPILLARY CARCINOMA; THYROID FUNCTION TEST; THYROID TUMOR; WHOLE BODY RADIATION;

ADOLESCENT; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; HUMANS; MALE; RECOMBINANT PROTEINS; THYROGLOBULIN; THYROID FUNCTION TESTS; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; WHOLE-BODY IRRADIATION;

EID: 21444458941     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345384     Document Type: Article

References (22)

1. Schlumberger MG. Papillary and follicular thyroid carcinoma. N Engl J Med 1998, 338: 297-306.
2. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid 2002, 2: 683-702.
3. Mazzaferri EL, Kloos RT. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions. Thyroid 2000, 10: 767-78.
4. Meier CA, Braverman LE, Ebner SA, et al. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (Phase I/II Study). J Clin Endocrinol Metab 1994, 78: 188-96.
5. Ladenson PW, Braverman LE, Mazzaferri EL, et al. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 1997, 337: 888-96.
6. Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin with withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999, 84: 3877-85.
7. Perros P. Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience. J Endocrinol Invest 1999, 22: 30-4.
8. Pellegriti G, Scollo C, Giuffrida D, et al. Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer. Thyroid 2001, 11: 1025-30.
9. Robbins RJ, Turtle RM, Sonenberg M, et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. Thyroid 2001, 11: 865-9.
10. Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982, 26: 1136-40.
11. Salvatori M, Saletnich I, Rufini V, et al. Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer. J Nucl Med 1998, 39: 1202-7.
12. 131I. J Nucl Med 2001, 42: 975-83.
13. Edmonds CJ, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986, 59: 45-51.
14. Van Nostrand D, Neutze J, Atkins F. Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med 1986, 27: 1519-27.
15. Roldan Schilling V, Fernandez Abellan P, et al. Acute leukemias after treatment with radioiodine for thyroid cancer. Haematologica 1998, 83: 767-8.
16. 131I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 2002, 87: 4063-68.
17. Vitale G, Lupoli GA, Ciccarelli A, et al. Influence of body surface area on serum peak thyrotropin (TSH) levels after recombinant human TSH administration. J Clin Endocrinol Metab 2003, 88: 1319-22.
18. Braga M, Ringel MD, Cooper DS. Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration. J Clin Endocrinol Metab 2001, 86: 5148-51.
19. Robbins RJ, Voelker E, Wang W, Macapinlac HA, Larson SM. Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case reports and review of literature. Endocr Pract 2000, 6: 460-4.
20. Lippi F, Capezzaone M, Angelini F, et al. Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. Eur J Endocrinol 2001, 144: 5-11.
21. Harach HR, Williams ED. Childhood thyroid cancer in England and Wales. Br J Cancer 1995, 72: 777-83.
22. Giuffrida D, Scollo C, Pellegriti G, et al. Differentiated thyroid cancer in children and adolescents. J Endocrinol Invest 2002, 25: 18-24.